Ranodhi N Serrao
Examiner (ID: 2922, Phone: (571)272-7967 , Office: P/2444 )
Most Active Art Unit | 2444 |
Art Unit(s) | 2141, 2441, 2444 |
Total Applications | 770 |
Issued Applications | 619 |
Pending Applications | 47 |
Abandoned Applications | 100 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16459426
[patent_doc_number] => 10842753
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-24
[patent_title] => Modified alginates for cell encapsulation and cell therapy
[patent_app_type] => utility
[patent_app_number] => 16/408899
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 15111
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16408899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/408899 | Modified alginates for cell encapsulation and cell therapy | May 9, 2019 | Issued |
Array
(
[id] => 16704397
[patent_doc_number] => 10954317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-23
[patent_title] => Process for preparing alkali metal salt of carboxyalkyl ether of tamarind gum
[patent_app_type] => utility
[patent_app_number] => 16/616074
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 8
[patent_no_of_words] => 7870
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16616074
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/616074 | Process for preparing alkali metal salt of carboxyalkyl ether of tamarind gum | May 9, 2019 | Issued |
Array
(
[id] => 17052162
[patent_doc_number] => 20210261596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => METHOD FOR PREPARING OLIGONUCLEIC ACID COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/053448
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053448
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053448 | Method for preparing oligonucleic acid compound | May 9, 2019 | Issued |
Array
(
[id] => 16665136
[patent_doc_number] => 10934369
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-02
[patent_title] => Hypromellose phthalate and method for producing the same
[patent_app_type] => utility
[patent_app_number] => 16/407871
[patent_app_country] => US
[patent_app_date] => 2019-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3708
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16407871
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/407871 | Hypromellose phthalate and method for producing the same | May 8, 2019 | Issued |
Array
(
[id] => 14864729
[patent_doc_number] => 20190282606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => INHIBITORS OF ADAMTS4 OR ADAMTS5 FOR USE IN PREVENTING OR TREATING CARDIAC REMODELING AND CHRONIC HEART FAILURE
[patent_app_type] => utility
[patent_app_number] => 16/403882
[patent_app_country] => US
[patent_app_date] => 2019-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15626
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16403882
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/403882 | Inhibitors of ADAMTS4 or ADAMTS5 for use in preventing or treating cardiac remodeling and chronic heart failure | May 5, 2019 | Issued |
Array
(
[id] => 14712695
[patent_doc_number] => 20190247411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-15
[patent_title] => METHOD OF TREATING HETEROTOPIC OSSIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/397029
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6116
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397029
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397029 | Method of treating heterotopic ossification | Apr 28, 2019 | Issued |
Array
(
[id] => 17162964
[patent_doc_number] => 11149051
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Compositions and methods of modulating the immune response by activating alpha protein kinase 1
[patent_app_type] => utility
[patent_app_number] => 16/395463
[patent_app_country] => US
[patent_app_date] => 2019-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 57
[patent_no_of_words] => 42518
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 556
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16395463
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/395463 | Compositions and methods of modulating the immune response by activating alpha protein kinase 1 | Apr 25, 2019 | Issued |
Array
(
[id] => 16748814
[patent_doc_number] => 20210100823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-08
[patent_title] => USE OF GINSENOSIDE M1 FOR TREATING HUNTINGTON'S DISEASE
[patent_app_type] => utility
[patent_app_number] => 16/960932
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7870
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16960932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/960932 | USE OF GINSENOSIDE M1 FOR TREATING HUNTINGTON'S DISEASE | Apr 22, 2019 | Pending |
Array
(
[id] => 19120080
[patent_doc_number] => 11964041
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Compositions comprising levan and use thereof
[patent_app_type] => utility
[patent_app_number] => 17/047523
[patent_app_country] => US
[patent_app_date] => 2019-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 41
[patent_no_of_words] => 12486
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047523
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047523 | Compositions comprising levan and use thereof | Apr 14, 2019 | Issued |
Array
(
[id] => 16198910
[patent_doc_number] => 10724062
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-28
[patent_title] => Biosynthetic production of steviol glycosides and processes therefore
[patent_app_type] => utility
[patent_app_number] => 16/382280
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 21
[patent_no_of_words] => 18847
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382280
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/382280 | Biosynthetic production of steviol glycosides and processes therefore | Apr 11, 2019 | Issued |
Array
(
[id] => 17156104
[patent_doc_number] => 20210317155
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => Crystals of Glycyrrhizic Acid Derivatives, Crystalline Compositions, Pharmaceutical Compositions and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 17/047292
[patent_app_country] => US
[patent_app_date] => 2019-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17047292
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/047292 | Crystals of glycyrrhizic acid derivatives, crystalline compositions, pharmaceutical compositions and uses thereof | Apr 11, 2019 | Issued |
Array
(
[id] => 16900901
[patent_doc_number] => 20210179817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => PURIFICATION OF SUGAMMADEX
[patent_app_type] => utility
[patent_app_number] => 17/045736
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1943
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045736
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/045736 | Purification of sugammadex | Apr 7, 2019 | Issued |
Array
(
[id] => 15023385
[patent_doc_number] => 20190322697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => 2'2'-CYCLIC DINUCLEOTIDES
[patent_app_type] => utility
[patent_app_number] => 16/375134
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375134
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/375134 | 2'2'-CYCLIC DINUCLEOTIDES | Apr 3, 2019 | Abandoned |
Array
(
[id] => 14624543
[patent_doc_number] => 20190225639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => PROCESS FOR THE PREPARATION OF DIOSMIN
[patent_app_type] => utility
[patent_app_number] => 16/373118
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5771
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16373118
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/373118 | Process for the preparation of diosmin | Apr 1, 2019 | Issued |
Array
(
[id] => 16168190
[patent_doc_number] => 10709730
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Hydroxypropyl beta-cyclodextrin compositions and methods
[patent_app_type] => utility
[patent_app_number] => 16/372899
[patent_app_country] => US
[patent_app_date] => 2019-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 50
[patent_figures_cnt] => 63
[patent_no_of_words] => 44262
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16372899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/372899 | Hydroxypropyl beta-cyclodextrin compositions and methods | Apr 1, 2019 | Issued |
Array
(
[id] => 14624547
[patent_doc_number] => 20190225641
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => Crystal Forms of Beta-Nicotinamide Mononucleotide
[patent_app_type] => utility
[patent_app_number] => 16/368052
[patent_app_country] => US
[patent_app_date] => 2019-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18461
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16368052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/368052 | Crystal forms of beta-nicotinamide mononucleotide | Mar 27, 2019 | Issued |
Array
(
[id] => 16598128
[patent_doc_number] => 20210024659
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => NOVEL REACTIVE ALGINIC ACID DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 17/041036
[patent_app_country] => US
[patent_app_date] => 2019-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041036
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/041036 | Reactive alginic acid derivatives | Mar 26, 2019 | Issued |
Array
(
[id] => 14893811
[patent_doc_number] => 20190290671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-26
[patent_title] => HYPOLIPIDEMIC EFFECTS OF COMPOSITIONS COMPRISING BETA-GLUCOGALLIN
[patent_app_type] => utility
[patent_app_number] => 16/361457
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4187
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16361457
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/361457 | HYPOLIPIDEMIC EFFECTS OF COMPOSITIONS COMPRISING BETA-GLUCOGALLIN | Mar 21, 2019 | Abandoned |
Array
(
[id] => 17769366
[patent_doc_number] => 11401293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Oligosaccharide c-glycoside derivatives
[patent_app_type] => utility
[patent_app_number] => 17/040346
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12592
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17040346
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/040346 | Oligosaccharide c-glycoside derivatives | Mar 21, 2019 | Issued |
Array
(
[id] => 18666311
[patent_doc_number] => 11773189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => Pectin characterized by a low degree of methyl esterification and a high intrinsic viscosity
[patent_app_type] => utility
[patent_app_number] => 16/971572
[patent_app_country] => US
[patent_app_date] => 2019-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 7893
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971572
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/971572 | Pectin characterized by a low degree of methyl esterification and a high intrinsic viscosity | Mar 17, 2019 | Issued |